QNRX - Quoin Pharmaceuticals, Ltd.

5.7
-0.030   -0.526%

Share volume: 101,177
Last Updated: 04-24-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$5.73
-0.03
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
32%
Profitability 35%
Dept financing 43%
Liquidity 20%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-0.70%
1 Month
-11.08%
3 Months
-39.62%
6 Months
-56.82%
1 Year
-13.64%
2 Year
732.00%
Key data
Stock price
$5.70
P/E Ratio 
N/A
DAY RANGE
$5.32 - $5.90
EPS 
-$23.56
52 WEEK RANGE
$5.32 - $41.80
52 WEEK CHANGE
-$13.64
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
64.931 M
DIVIDEND
$0.00
EX-DIVIDEND DATE
04-09-2025
NEXT EARNINGS DATE
05-08-2025
BETA 
-0.23
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$34,985
AVERAGE 30 VOLUME 
$41,234
Company detail
CEO: Michael Myers
Region: US
Website: quoinpharma.com
Employees: 4
IPO year: 2016
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Quoin Pharmaceuticals, Ltd. focuses on the development of therapeutic products for rare and orphan diseases. It offers QRX003, a topical lotion to treat Netherton Syndrome; QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease.

Recent news